It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2013.
2013 | Bangalore, Karnataka, India | ActiveRmeex Pharmaceutical Private Limited, a active private limited company, was established on 29 July 2013 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900KA2013PTC070356. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Pratap Chandra Nayak (Director), Rajesh Kumar Dash (Director). It holds ₹3.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Sy No. 43, 4Th Floor, Sgr Plaza, Varthur Main Road, Marathahalli,, Bangalore, Karnataka, 560037.
U74900KA2013PTC070356
070356
29 July 2013
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Rmeex Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pratap Chandra Nayak | Director | 29 Jul 2013 | Current |
| Rajesh Kumar Dash | Director | 29 Jul 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rmeex Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 112.72% increase. The company also saw a substantial improvement in profitability, with a 93.49% increase in profit. The company's net worth dipped by a decrease of 8.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Rmeex Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Feb 2024 | Others | ₹3.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rmeex Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rmeex Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rmeex Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 3.50 M with Charge ID 100898975 was registered on 29 Feb 2024. was documented.
Progress on Rmeex Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
The activity Rmeex Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was completed.
Pratap Chandra Nayak was appointed as a Director was appointed as a Director on 29 Jul 2013 & has been associated with this company since 12 years 4 months . was recorded as a recent event.
Progress on Rajesh Kumar Dash was appointed as a Director was appointed as a Director on 29 Jul 2013 & has been associated with this company since 12 years 4 months . was documented.
Progress on Rmeex Pharmaceutical Private Limited was registered on 29 Jul 2013 with Roc Bangalore & aged 12 years 4 months as per MCA records. was documented.
The CIN of Rmeex Pharmaceutical Private Limited is U74900KA2013PTC070356.
Rmeex Pharmaceutical Private Limited is headquartered at Sy No. 43, 4Th Floor, Sgr Plaza, Varthur Main Road, Marathahalli,, Bangalore, Karnataka, 560037.
Rmeex Pharmaceutical Private Limited was incorporated on 29 July 2013.
The current directors of Rmeex Pharmaceutical Private Limited are
The primary industry of Rmeex Pharmaceutical Private Limited is Trade.
Rmeex Pharmaceutical Private Limited is unlisted.
The authorized capital of Rmeex Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Rmeex Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX